Found: 6
Select item for more details and to access through your institution.
Targeting Aurora kinase A and JAK2 prevents GVHD while maintaining T<sub>reg</sub> and antitumor CTL function.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 372, p. 1, doi. 10.1126/scitranslmed.aai8269
- By:
- Publication type:
- Article
Disruptive reproductive technologies.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 372, p. 1, doi. 10.1126/scitranslmed.aag2959
- By:
- Publication type:
- Article
A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 372, p. 1, doi. 10.1126/scitranslmed.aag2611
- By:
- Publication type:
- Article
Post hoc assessment of the immunogenicity of bioengineered factor VIIa demonstrates the use of preclinical tools.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 372, p. 1, doi. 10.1126/scitranslmed.aag1286
- By:
- Publication type:
- Article
CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 372, p. 1, doi. 10.1126/scitranslmed.aah3480
- By:
- Publication type:
- Article
Pharmacological rescue of diabetic skeletal stem cell niches.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 372, p. 1, doi. 10.1126/scitranslmed.aag2809
- By:
- Publication type:
- Article